MicroCurrent Stimulation (MCS) is an enhanced adaptation of a FDA approved therapy used by anesthesiologists, orthopedic surgeons, plastic surgeons and rehabilitative specialists to promote the healing of wounds and transplanted tissues as well as to treat pain. The treatment of patients with Macular Degeneration, Stargardt's and Retinitis Pigmentosa entails the periodic administration of very precise amounts of tightly controlled electrical current through electrodes applied to the skin at specific areas around the eye. The electrical current is used to stimulate the retina as well as the diseased macula in order to restore sight. The procedure is safe, non-invasive
and painless and no side effects or adverse
reactions have been observed.

ScyFIX offers the only patented Micro Current Stimulation device for the treatment of Macular Degeneration, Stargardt's, Retinitis Pigmentosa and other degenerative eye diseases. Studies have shown that micro-current stimulation can improve the vision for 85% of those suffering from Macular Degeneration, 83% of those suffering from Stargardt's disease, and 2/3 of those suffering from Retinitis Pigmentosa. In patients who have improved, an increase in brightness and a decrease in fogginess are usually the first changes noted. Other changes include an increase in visual acuity, enhanced color perception and a decrease in the size and/or density of the blind spot. Importantly, micro-current stimulation has also proven to expand the visual field for both Macular Degeneration and Retinitis Pigmentosa.